Pharmafile Logo

Goffin Consultancy Ltd

We are a consultancy, set up in early 1999, specialising in health economic analysis and systematic reviews of clinical data. We may be relatively small but we have an unusual depth of experience of the pharmaceutical industry – and if we don’t know, we almost certainly know someone who does! We also have a wide medical expertise in all aspects of medical and regulatory affairs and are able to assist smaller companies directly or on behalf of Private Equity / Venture Capitol companies. Depending on the project, we can bring in experts in a variety of fields including: medical affairs; market research, surveys; strategic planning; sales; market commercialization.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Riding House, Bossingham Road, Stelling Minnis, Canterbury, Kent, CT4 6AZ, United Kingdom
+44 (0)122 7709220

 Latest Content from PMHub 

Rare Diseases – not as rare as you think

Julie Cox reflects on our passion working in the rare disease space - helping to bring vital education to healthcare professionals, to benefit patients

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Rare and Orphan Diseases

Why we need authentic and personalised communications in the evolving rare disease space. By Sarah Mikhailov, Managing Director, Brand at Havas Life Medicom

Origins’ Strategy Offering Explained

What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy...

Applying Vibrotactile Stimulation to Improve Parkinson’s

Videos and Podcasts | February 16, 2023 | Impetus Digital

Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

Impetus Digital’s Virtual Learning Programs named PM360’s Most Innovative Services of 2022

Press Releases | February 16, 2023 | Impetus Digital

About the AwardToronto, ON, December 15, 2022 — PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Impetus Digital’s Virtual...

End-to-end patient strategy: Making a treatment for patients, with patients

The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Press Releases | February 13, 2023 | OPEN Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...